R. Griffiths

发表

Cost-effectiveness of Prosorba column therapy for rheumatoid arthritis: a framework for analysis.

R. Griffiths, J. E. Slurzberg, 2001, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.

Economic impact of immunization against rotavirus gastroenteritis. Evidence from a clinical trial.

N. Powe, G. Anderson, C. Grant, 1995, Archives of pediatrics & adolescent medicine.

Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK

K. Khunti, K. Ray, M. Gleeson, 2016, BMJ Open.

Inverse probability weighted least squares regression in the analysis of time-censored cost data: an evaluation of the approach using SEER-Medicare.

A. O'Hagan, M. Gleeson, M. Danese, 2012, Value in Health.

Methods for estimating costs in patients with hyperlipidemia experiencing their first cardiovascular event in the United Kingdom

M. Gleeson, M. Danese, R. Griffiths, 2017, Journal of medical economics.

Impact of subsequent metastases on costs and medical resource use for prostate cancer patients initially diagnosed with localized disease

M. Mehra, N. Shore, R. Griffiths, 2017, Cancer.

Access to recombinant erythropoietin by Medicare-entitled dialysis patients in the first year after FDA approval.

N. Powe, P. Whelton, G. de Lissovoy, 1992, JAMA.

Diabetes in elderly patients with breast cancer in the United States: An analysis of data from the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database.

C. O’Malley, K. Lindquist, M. Gleeson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)

K. Knopf, M. Gleeson, M. Danese, 2010, BMC Cancer.

Health care utilization and mortality among elderly patients with myelodysplastic syndromes

K. Knopf, K. Lindquist, M. Danese, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

An observational study of outcomes after initial infused therapy in Medicare patients diagnosed with chronic lymphocytic leukemia.

K. Knopf, C. Reyes, M. Gleeson, 2011, Blood.

Survival in elderly follicular lymphoma patients who receive frontline chemo‐immunotherapy

K. Knopf, C. Reyes, M. Gleeson, 2010, American journal of hematology.

Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis.

R. Chaisson, C. Chaulk, R. Moore, 1996, American journal of respiratory and critical care medicine.

Cost-Effectiveness Analysis of Vagal Nerve Blocking for Morbid Obesity

Jeffrey C. Yu, B. Wolfe, R. Rosenthal, 2017 .

Cost implications to Medicare of recombinant erythropoietin therapy for the anemia of end-stage renal disease.

N. Powe, E. Bass, R. Griffiths, 1993, Journal of the American Society of Nephrology : JASN.

Simulated Lifetime Costs of Three Types of Employer-Based, Periodic, Breast Cancer Screening Programs for Working-Age Women

N. Powe, R. Griffiths, C. Griffiths, 1994, American journal of health promotion : AJHP.

The Relationship of Provider Organizational Status and Erythropoietin Dosing in End Stage Renal Disease Patients

N. Powe, P. Whelton, G. de Lissovoy, 1994, Medical care.

Economic savings and costs of periodic mammographic screening in the workplace.

V. Vogel, R. Griffiths, M. McGrath, 1996, Oncology.

Patterns of Hemodialysis Catheter Dysfunction Defined According to National Kidney Foundation Guidelines As Blood Flow <300 mL/min

G. Block, M. Danese, Britt B. Newsome, 2011, International journal of nephrology.

A Workplace Breast Cancer Screening Program

R. Griffiths, C. Griffiths, P. Schrammel, 1998, AAOHN journal : official journal of the American Association of Occupational Health Nurses.

PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.

G. Chertow, Q. Doan, M. Danese, 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Early dosing practices and effectiveness of recombinant human erythropoietin.

N. Powe, P. Whelton, G. de Lissovoy, 1993, Kidney International.

Medical Resource Use and Cost of Venlafaxine or Tricyclic Antidepressant Therapy

H. Goldman, R. Frank, R. Griffiths, 1999, PharmacoEconomics.

Temporal Trends of Device-Related Infection in De Novo Transvenous Implantable Cardioverter-Defibrillator Medicare Patients with Underlying Kidney Disease.

B. Knight, Yiyan Liu, M. Sohail, 2022, Heart rhythm.

Medicare payment policy and recombinant erythropoietin prescribing for dialysis patients.

N. Powe, P. Whelton, G. de Lissovoy, 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Cost-effectiveness of a paclitaxel-eluting stent (Eluvia) compared to Zilver PTX for endovascular femoropopliteal intervention

R. Akehurst, M. Jaff, S. Amorosi, 2022, Journal of medical economics.

A Review of the First Year of Medicare Coverage of Erythropoietin

N. Powe, P. Whelton, G. de Lissovoy, 1994, Health care financing review.

Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis.

A. Nissenson, B. Dean, R. Dubois, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.

R. Griffiths, S. Duff, M. Stovsky, 2006, The Journal of urology.

An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancer

C. O’Malley, K. Lindquist, M. Gleeson, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Medical costs of treating venous stasis ulcers: evidence from a retrospective cohort study

J. Olin, K. Beusterien, R. Griffiths, 1999, Vascular medicine.

Efficacy of immune globulin in preventing complications of bone marrow transplantation: a meta-analysis.

S. Goodman, E. Bass, J. Wingard, 1993, Bone marrow transplantation.

Costs of Managing Helicobacter pylori‐Infected Ulcer Patients after Initial Therapy

D. Graham, L. Rabeneck, R. Griffiths, 2001 .

Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study

K. Khunti, K. Ray, M. Gleeson, 2017, BMJ Open.

Costs and charges associated with three alternative techniques of hysterectomy

E. Steinberg, R. Griffiths, M. McGrath, 1996, The New England journal of medicine.

Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma.

M. Dreyling, M. Gleeson, M. Danese, 2011, Blood.

Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infections

V. Fowler, K. Kaye, D. Crosslin, 2008, Scandinavian journal of infectious diseases.

Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes.

K. Schulman, V. Fowler, K. Kaye, 2005, The American journal of medicine.

Effect of Central Nervous System Metastases on Treatment Discontinuation and Survival in Older Women Receiving Trastuzumab for Metastatic Breast Cancer

K. Lindquist, M. Danese, R. Griffiths, 2012, Journal of cancer epidemiology.

Granulocyte-Colony Stimulating Factor Use and Medical Costs after Initial Adjuvant Chemotherapy in Older Patients with Early-Stage Breast Cancer

A. O'Hagan, G. Lyman, J. Legg, 2012, PharmacoEconomics.

Factors influencing third party payer costs for allogeneic BMT.

S. Goodman, E. Bass, G. Anderson, 1993, Bone marrow transplantation.

The clinical-economic trial: promise, problems, and challenges.

N. Powe, R. Griffiths, 1995, Controlled clinical trials.

Catheter use is high even among hemodialysis patients with a fistula or graft.

A. Nissenson, R. Dubois, M. Danese, 2006, Kidney international.

Costs and Outcomes Among Hemodialysis-Dependent Patients With Methicillin-Resistant or Methicillin-Susceptible Staphylococcus aureus Bacteremia

K. Anstrom, K. Schulman, L. Szczech, 2005, Infection Control & Hospital Epidemiology.

Economic burden of cardiovascular events and fractures among patients with end-stage renal disease*

R. Dubois, Q. Doan, M. Gleeson, 2007, Current medical research and opinion.

Impact of Hemodialysis Catheter Dysfunction on Dialysis and Other Medical Services: An Observational Cohort Study

G. Block, M. Danese, Britt B. Newsome, 2012, International journal of nephrology.

Treatment patterns, survival, and hospitalization in adult patients with acute lymphoblastic leukemia: an observational cohort study using SEER Medicare data

M. Kelsh, M. Gleeson, M. Danese, 2019, Leukemia & lymphoma.

Septicemia in patients with ESRD is associated with decreased hematocrit and increased use of erythropoietin.

A. Nissenson, R. Dubois, R. Griffiths, 2006, Clinical journal of the American Society of Nephrology : CJASN.

Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patients.

K. Schulman, V. Fowler, S. Reed, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Effect of recombinant erythropoietin on hospital admissions, readmissions, length of stay, and costs of dialysis patients.

N. Powe, P. Whelton, G. de Lissovoy, 1994, Journal of the American Society of Nephrology : JASN.

Second-line therapy in diffuse large B-cell lymphoma (DLBCL): treatment patterns and outcomes in older patients receiving outpatient chemotherapy

M. Dreyling, M. Gleeson, M. Danese, 2017, Leukemia & lymphoma.

Validating the Follicular Lymphoma International Prognostic Index (FLIPI) Using SEER-Medicare Claims Data

K. Knopf, M. Gleeson, M. Danese, 2008 .

Quality of diabetes care in cancer: a systematic review

N. Keating, C. Bankhead, R. Griffiths, 2018, International journal for quality in health care : journal of the International Society for Quality in Health Care.

Impact on Medical Cost, Cumulative Survival, and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma in Elderly Patients: An Observational Cohort Study Based on SEER-Medicare

M. Gleeson, M. Danese, J. Mikhael, 2012, Journal of cancer epidemiology.

Identifying Primary Care Pathways from Quality of Care to Outcomes and Satisfaction Using Structural Equation Modeling

J. Valderas, I. Ricci-Cabello, John L Campbell, 2018, Health services research.

Comparison of the Rating Scale and the Standard Gamble in Measuring Patient Preferences for Outcomes of Gallstone Disease

E P Steinberg, K. Lillemoe, H. Pitt, 1994, Medical decision making : an international journal of the Society for Medical Decision Making.

Medical-Resource Use for Suspected Tuberculosis in a New York City Hospital

Samy I McFarlane, M. Sierra, R. Griffiths, 1998, Infection Control & Hospital Epidemiology.

Pharmacoeconomic Analysis of 3 Treatment Strategies for Cytomegalovirus Retinitis in Patients with AIDS

D. Dieterich, D. Jabs, E. Steinberg, 1998, PharmacoEconomics.

Clinical Outcomes and Costs Due to Staphylococcus aureus Bacteremia Among Patients Receiving Long-Term Hemodialysis

K. Schulman, L. Szczech, V. Fowler, 2005, Infection Control & Hospital Epidemiology.

Impact of the Prevalence of Concordant and Discordant Conditions on the Quality of Diabetes Care in Family Practices in England

Sarah Stevens, Evangelos Kontopantelis, Tim Doran, 2015, The Annals of Family Medicine.

Misclassification of incident conditions using claims data: impact of varying the period used to exclude pre-existing disease

C. O’Malley, M. Danese, R. Griffiths, 2013, BMC Medical Research Methodology.

P. Lambiase, B. Knight, M. Biffi, 2022, Journal of cardiovascular electrophysiology.

Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare

J. Valderas, M. Gleeson, M. Danese, 2012, BMC Cancer.

Mortality differences among organisms causing septicemia in hemodialysis patients

A. Nissenson, R. Dubois, M. Danese, 2006, Hemodialysis international. International Symposium on Home Hemodialysis.

Comparative effectiveness and cost of adding rituximab to first‐line chemotherapy for elderly patients diagnosed with diffuse large B‐cell lymphoma

M. Dreyling, M. Gleeson, M. Danese, 2012, Cancer.

Cost to Medicare of Acute Kidney Injury in Percutaneous Coronary Intervention.

C. Solid, R. Griffiths, A. Amin, 2023, American heart journal.

Impact of Undetected Comorbidity on Treatment and Outcomes of Breast Cancer

J. Valderas, M. Gleeson, M. Danese, 2014, International journal of breast cancer.

Prevalence and incidence of comorbidities in elderly women with ovarian cancer.

C. O’Malley, M. Kelsh, K. Lindquist, 2013, Gynecologic oncology.

Patterns of disease-modifying antirheumatic drug use, medical resource consumption, and cost among rheumatoid arthritis patients.

E. Yelin, C. MacLean, R. Griffiths, 2001, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.

Medical resource use and costs among rheumatoid arthritis patients receiving disease-modifying antirheumatic drug therapy.

E. Yelin, C. MacLean, R. Griffiths, 2000, Arthritis care and research : the official journal of the Arthritis Health Professions Association.

Infused Therapy and Survival in Older Patients Diagnosed with Metastatic Breast Cancer who Received Trastuzumab

M. Danese, R. Griffiths, R. Herbert, 2011, Cancer investigation.

P. Lambiase, B. Knight, M. Biffi, 2021, Heart rhythm.

The production of dialysis by for-profit versus not-for-profit freestanding renal dialysis facilities.

N. Powe, P. Whelton, G. Anderson, 1994, Health services research.

Costs and complications associated with transvenous lead reoperation in cardiac implantable electronic devices

J. Menzin, S. Amorosi, M. Reynolds, 2020, Journal of cardiovascular electrophysiology.

Outcomes of preexisting diabetes mellitus in breast, colorectal, and prostate cancer

N. Keating, J. Valderas, R. Stevens, 2017, Journal of Cancer Survivorship.

Quality of diabetes care in breast, colorectal, and prostate cancer

N. Keating, J. Valderas, R. Stevens, 2018, Journal of Cancer Survivorship.

Undiagnosed Diabetes in Breast, Colorectal, Lung, and Prostate Cancer: Incidence and Risk Factors

J. Valderas, C. O’Malley, K. Lindquist, 2014, ISRN oncology.